Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Critical remarks regarding guidelines based on scientific research].

O E Nieweg1

  • 1Het Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis, afd. Heelkunde, Plesmanlaan 121, 1066 CX Amsterdam. o.nieweg@nki.nl

Nederlands Tijdschrift Voor Geneeskunde
|July 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Hypofractionated or Conventionally Fractionated Adjuvant Radiotherapy After Regional Lymph Node Dissection for High-Risk Stage III Melanoma.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data.

The British journal of surgery·2021
Same author

Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.

Nature medicine·2021
Same author

ASO Author Reflections: Ultrasound Assessment of the Lymphatic Drainage Area in Melanoma Patients With In-Transit Metastases.

Annals of surgical oncology·2020

Medical guidelines are essential but not always evidence-based, sometimes relying on personal opinions over scientific studies. Doctors often need to deviate from guidelines for patients who don't fit the average profile.

Area of Science:

  • Medical Interventions
  • Clinical Practice Guidelines
  • Evidence-Based Medicine

Background:

  • National and international guidelines are increasingly used as standards for medical diagnosis and treatment.
  • The basis of evidence-based consensus guidelines is not consistently derived from scientific study outcomes.
  • Low-grade evidence from recent research may be superseded by subjective factors like personal impressions and common sense.

Discussion:

  • Guidelines are typically designed for the 'average' patient within a defined range.
  • Increasing medical specialization leads to doctors appropriately diverging from guidelines.
  • Deviations are justified when a patient's condition significantly differs from the average profile.

Key Insights:

  • The foundation of clinical guidelines requires consistent linkage to robust scientific evidence.

Related Experiment Videos

  • Subjective influences can potentially override objective research findings in guideline development.
  • Personalized medicine necessitates flexibility in applying standardized treatment protocols.
  • Outlook:

    • Future guidelines should prioritize stronger empirical evidence to enhance reliability.
    • Developing adaptive guideline frameworks that accommodate patient variability is crucial.
    • Promoting critical appraisal of guidelines alongside clinical judgment will improve patient care.